{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:49:35Z","timestamp":1775947775392,"version":"3.50.1"},"reference-count":40,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Japanese Red Cross Blood Services archives donor blood samples from all donations for look-back surveys. These samples, approximately 5 million per year, are stored frozen at \u201330\u00b0C for 11 years and are subsequently discarded. Because such samples may also be valuable for antibody-related research and other purposes after the mandated storage period, we evaluated their potential applicability, with a particular focus on the preservation of anti- body levels. Fresh samples were compared with frozen-stored samples (\u201330\u00b0C for 14 years: 11 years of mandatory good manufacturing practice storage period + 3 years until measurement) for immunoglobulin levels (IgM, IgG, IgA, and IgE) as a general indicator of humoral immunity, tetanus toxin antibody titers as a long-lived vaccine-induced antibody, and ABO antibody titers (saline-direct agglutination test and saline-indirect antiglobulin test [saline-IAT]), which are factors in blood group typing and hemolytic transfusion reactions. For immunoglobulin levels, comparisons of non-paired fresh and frozen-stored samples were made from a random donor population (IgM, IgG, IgA: 105 cases each, IgE: 32 cases). For tetanus toxin antibody and ABO antibody, comparisons were conducted from the same donors with fresh and frozen-stored samples (tetanus toxin antibody: 47 cases, ABO antibody: 12 cases). No significant differences were observed in immunoglobulin levels, tetanus toxin antibody titers, or ABO antibody titers measured by the saline-direct agglutination method. Saline-IAT\u2013measured ABO antibody titers were significantly lower in frozen-stored samples. Detailed results were as follows: (1) Median immunoglobulin levels (fresh vs. frozen-stored): IgM, 78.5 mg\/dL versus 86.7 mg\/dL; IgG, 1240.2 mg\/dL versus 1280.2 mg\/dL; IgA, 241.0 mg\/dL versus 245.3 mg\/dL; and IgE, 0.24 \u03bcg\/mL versus 0.12 \u03bcg\/mL. (2) Tetanus toxin antibody titers\u2014geometric mean titer (GMT) (95% confidence interval [CI]): fresh 0.23 (0.12\u20130.43) IU\/mL versus frozen-stored 0.28 (0.17\u20130.46) IU\/mL. (3) ABO antibody titers\u2014GMT (95% CI): saline-direct agglutination, fresh 65.4 (33.3\u2013128.5) versus frozen-stored 51.7 (24.9\u2013107.4); saline-IAT, fresh 391.0 (160.3\u2013953.6) versus frozen-stored 248.7 (107.8\u2013573.6). The evaluated immunoglobulin levels were largely preserved, suggesting that archived blood samples retain sufficient stability for antibody research. However, careful study design is necessary to minimize potential sample deterioration.<\/jats:p>","DOI":"10.2478\/immunohematology-2026-003","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:11Z","timestamp":1775946791000},"page":"6-13","source":"Crossref","is-referenced-by-count":0,"title":["Effect of long-term frozen storage on antibodies in blood samples: immunoglobulin, tetanus toxin antibody, and ABO antibody"],"prefix":"10.2478","volume":"42","author":[{"given":"Masamichi","family":"Mikame","sequence":"first","affiliation":[{"name":"Japanese Red Cross Central Blood Institute , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kitazaki","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Hokkaido Block Blood Center , Hokkaido , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Hokkaido Block Blood Center , Hokkaido , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Kanto-Koshinetsu Block Blood Center , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miyagi","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Kanto-Koshinetsu Block Blood Center , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Central Blood Institute , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Onodera","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Kanto-Koshinetsu Block Blood Center , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson H.","family":"Tsuno","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Kanto-Koshinetsu Block Blood Center , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Miyata","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Central Blood Institute , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Tani","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Central Blood Institute , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kino","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Blood Service Headquarters , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Muroi","sequence":"additional","affiliation":[{"name":"Japanese Red Cross Kanto-Koshinetsu Block Blood Center , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"2026041122330574168_j_immunohematology-2026-003_ref_001","doi-asserted-by":"crossref","unstructured":"Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022;375:296\u2013301. doi: 10.1126\/science.abj8222.","DOI":"10.1126\/science.abj8222"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_002","doi-asserted-by":"crossref","unstructured":"Mazda T, Yabe R, Nathalang O, et al. Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations. Immunohematology 2007;23:38\u201341. doi: 10.21307\/immunohematology-2019-316.","DOI":"10.21307\/immunohematology-2019-316"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_003","doi-asserted-by":"crossref","unstructured":"Satake M. Transfusion medicine illustrated: Japanese repositories. Transfusion 2007;47:1105. doi: 10.1111\/j.1537-2995. 2007.01359.x.","DOI":"10.1111\/j.1537-2995.2007.01359.x"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_004","doi-asserted-by":"crossref","unstructured":"Satake M, Hoshi Y, Taira R, et al. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011;51:1887\u201395. doi: 10.1111\/j.1537-2995.2010.03047.x.","DOI":"10.1111\/j.1537-2995.2010.03047.x"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_005","doi-asserted-by":"crossref","unstructured":"Satake M, Taira R, Yugi H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007;47:1197\u2013205. doi: 10.1111\/j.1537-2995.2007.01276.x.","DOI":"10.1111\/j.1537-2995.2007.01276.x"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_006","doi-asserted-by":"crossref","unstructured":"Yoshikawa A, Gotanda Y, Minegishi K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007;47:1162\u201371. doi: 10.1111\/j.1537-2995.2007.01234.x.","DOI":"10.1111\/j.1537-2995.2007.01234.x"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_007","doi-asserted-by":"crossref","unstructured":"Hamada Y, Fukutomi Y, Nakatani E, et al. Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis. Allergol Int 2021;70:74\u201380. doi: 10.1016\/j.alit.2020.07.006.","DOI":"10.1016\/j.alit.2020.07.006"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_008","doi-asserted-by":"crossref","unstructured":"Kitahara A, Yamamoto Y, Fukutomi Y, et al. Sensitization pattern to environmental allergens in a Japanese population. J Allergy Clin Immunol Glob 2023;2:30\u20135. doi: 10.1016\/j. jacig.2022.10.004.","DOI":"10.1016\/j.jacig.2022.10.004"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_009","doi-asserted-by":"crossref","unstructured":"Tanaka J, Fukutomi Y, Shiraishi Y, et al. Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population. Allergol Int 2022;71:117\u201324. doi: 10.1016\/j.alit.2021.08.009.","DOI":"10.1016\/j.alit.2021.08.009"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_010","doi-asserted-by":"crossref","unstructured":"Castro AR, Jost HA. Effect of multiple freeze and thaw cycles on the sensitivity of IgG and IgM immunoglobulins in the sera of patients with syphilis. Sex Transm Dis 2013;40:870\u20131. doi: 10.1097\/OLQ.0000000000000036.","DOI":"10.1097\/OLQ.0000000000000036"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_011","doi-asserted-by":"crossref","unstructured":"Cuhadar S, Koseoglu M, Atay A, et al. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb) 2013;23:70\u20137. doi: 10.11613\/bm.2013.009.","DOI":"10.11613\/BM.2013.009"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_012","doi-asserted-by":"crossref","unstructured":"Gislefoss RE, Lauritzen M, Langseth H, et al. Effect of multiple freeze-thaw cycles on selected biochemical serum components. Clin Chem Lab Med 2017;55:967\u201373. doi: 10.1515\/cclm-2016-0892.","DOI":"10.1515\/cclm-2016-0892"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_013","doi-asserted-by":"crossref","unstructured":"Hegemann A, Pardal S, Matson KD. Indices of immune function used by ecologists are mostly unaffected by repeated freeze-thaw cycles and methodological deviations. Front Zool 2017;14:43. doi: 10.1186\/s12983-017-0226-9.","DOI":"10.1186\/s12983-017-0226-9"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_014","doi-asserted-by":"crossref","unstructured":"Inada M, Togano T, Terada M, et al. Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma. Transfus Apher Sci 2023;62:103638. doi: 10.1016\/j.transci.2022.103638.","DOI":"10.1016\/j.transci.2022.103638"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_015","doi-asserted-by":"crossref","unstructured":"Laner-Plamberger S, Siller A, Lauth W, et al. Stable SARSCoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage. Vox Sang 2025;120:784\u201392. doi: 10.1111\/vox.70059.","DOI":"10.1111\/vox.70059"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_016","doi-asserted-by":"crossref","unstructured":"Pinsky NA, Huddleston JM, Jacobson RM, et al. Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies. Clin Diagn Lab Immunol 2003;10:19\u201321. doi: 10.1128\/cdli.10.1.19-21.2003.","DOI":"10.1128\/CDLI.10.1.19-21.2003"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_017","doi-asserted-by":"crossref","unstructured":"Torelli A, Gianchecchi E, Monti M, et al. Effect of repeated freeze-thaw cycles on influenza virus antibodies. Vaccines 2021;9:267. doi: 10.3390\/vaccines9030267.","DOI":"10.3390\/vaccines9030267"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_018","doi-asserted-by":"crossref","unstructured":"Dee TH, Berger CS. Stability of anti-Candida precipitating antibody in stored sera as determined by counter-immunoelectrophoresis. J Clin Microbiol 1979;10:593\u20134. doi: 10.1128\/jcm.10.4.593-594.1979.","DOI":"10.1128\/jcm.10.4.593-594.1979"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_019","unstructured":"Melnick JL, Wimberly IL. Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera stored frozen for two decades. Bull World Health Organ 1985;63:543\u201350."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_020","unstructured":"Affanni P, Colucci ME, Capobianco E, et al. Immunity status against tetanus in young migrants: a seroprevalence study. Acta Biomed 2020;91(Suppl 3):77\u201384. doi: 10.23750\/abm. v91i3-S.9438."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_021","doi-asserted-by":"crossref","unstructured":"Coplu N, Esen B, Gozalan A, et al. Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey. Jpn J Infect Dis 2004;57:97\u2013102. doi: 10.7883\/yoken.JJID.2004.97.","DOI":"10.7883\/yoken.JJID.2004.97"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_022","doi-asserted-by":"crossref","unstructured":"Ono S, Nakajima M, Yamana H, et al. Tetanus toxoid vaccination uptake by trauma patients in Japan: a retrospective cohort study using large administrative claims data. Vaccine 2025;49:126812. doi: 10.1016\/j.vaccine.2025.126812.","DOI":"10.1016\/j.vaccine.2025.126812"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_023","unstructured":"World Health Organization. WHO immunization data portal. Available from https:\/\/immunizationdata.who.int. Accessed 7 October 2025."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_024","doi-asserted-by":"crossref","unstructured":"Datta SS, Basu D, Basu S. Screening of group O platelet donors for high-titer ABO antibodies: limitations, feasibility, and future. Transfus Apher Sci 2022;61:103394. doi: 10.1016\/j. transci.2022.103394.","DOI":"10.1016\/j.transci.2022.103394"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_025","doi-asserted-by":"crossref","unstructured":"Sato T, Goto N, Tasaki T. Hemolytic transfusion reactions. N Engl J Med 2019;381:1396\u20137. doi: 10.1056\/NEJMc1910551.","DOI":"10.1056\/NEJMc1910551"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_026","doi-asserted-by":"crossref","unstructured":"Josephson CD, Castillejo MI, Grima K, et al. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010;42:83\u20138. doi: 10.1016\/j.transci.2009.10.013.","DOI":"10.1016\/j.transci.2009.10.013"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_027","doi-asserted-by":"crossref","unstructured":"Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48\u201359. doi: 10.21307\/immunohematology-2019-231.","DOI":"10.21307\/immunohematology-2019-231"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_028","doi-asserted-by":"crossref","unstructured":"Mikame M, Tsuno NH, Miura Y, et al. Anti-A and anti-B titers, age, gender, biochemical parameters, and body mass index in Japanese blood donors. Immunohematology 2023;39:155\u201365. doi: 10.2478\/immunohematology-2023-023.","DOI":"10.2478\/immunohematology-2023-023"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_029","unstructured":"Japanese Red Cross Society. Blood services 2024. Available from https:\/\/www.jrc.or.jp\/english\/activity\/blood\/. Accessed 7 October 2025."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_030","unstructured":"Japan Institute for Health Security. National epidemiological surveillance of vaccine-preventable diseases. Available from https:\/\/id-info.jihs.go.jp\/surveillance\/nesvpd\/en\/y-graphs\/index.html. Accessed 7 October 2025."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_031","unstructured":"Japan Institute for Health Security. Infectious agents surveillance report (tetanus in Japan as of December 2008). Available from https:\/\/idsc.niid.go.jp\/iasr\/30\/349\/tpc349.html. Accessed 7 October 2025."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_032","unstructured":"Dicker R, Coronado F, Koo D, et al. Measures of central location. In: Principles of epidemiology in public health practice: an introduction to applied epidemiology and biostatistics. 3rd ed. Centers for Disease Control and Prevention, 2006. Available from https:\/\/stacks.cdc.gov\/view\/cdc\/6914. Accessed 10 December 2025."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_033","doi-asserted-by":"crossref","unstructured":"Hamilton JR. Saline-indirect antiglobulin test. Immunohematology 2019;35:156\u20138. doi: 10.21307\/immunohematology-2020-032.","DOI":"10.21307\/immunohematology-2020-032"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_034","doi-asserted-by":"crossref","unstructured":"Pietersz RN, Engelfriet CP, Reesink HW. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88: 207\u201321. doi: 10.1111\/j.1423-0410.2005.00615.x.","DOI":"10.1111\/j.1423-0410.2005.00615.x"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_035","doi-asserted-by":"crossref","unstructured":"Cardigan R, New HV, Estcourt L, et al. International forum on policies and practice for transfusion of ABO and RhD non-identical platelets: responses. Vox Sang 2022;117:e1\u201320. doi: 10.1111\/vox.13130.","DOI":"10.1111\/vox.13130"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_036","doi-asserted-by":"crossref","unstructured":"Manikandan S. Measures of central tendency: the mean. J Pharmacol Pharmacother 2011;2:140\u20132. doi: 10.4103\/0976-500X.81920.","DOI":"10.4103\/0976-500X.81920"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_037","unstructured":"Reverberi R. The statistical analysis of immunohaematological data. Blood Transfus 2008;6:37\u201345. doi: 10.2450\/2008.0001-08."},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_038","doi-asserted-by":"crossref","unstructured":"Kanji JN, Heibati B, Zelyas N, et al. Utilization of tetanus and diphtheria serology tests in Alberta, Canada: patterns and implications. PLoS One 2025;20:e0336690. doi: 10.1371\/journal.pone.0336690.","DOI":"10.1371\/journal.pone.0336690"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_039","doi-asserted-by":"crossref","unstructured":"Mikame M, Tsuno NH, Miura Y, et al. Decreased rate of blood donors with high ABO antibody titers in Japan and the underlying factors: comparisons between 2010 and 2021. Transfus Apher Sci 2023;62:103812. doi: 2010.1016\/j. transci.2023.103812.","DOI":"10.1016\/j.transci.2023.103812"},{"key":"2026041122330574168_j_immunohematology-2026-003_ref_040","doi-asserted-by":"crossref","unstructured":"Miyazaki T, Isa K, Kurita R, et al. DSLK and Kg: antithetical antigens in the RHAG blood group system, and characterization of anti-DSLK antibody. Vox Sang 2023;118:392\u20137. doi: 10.1111\/vox.13425.0X0.","DOI":"10.1111\/vox.13425"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2026-003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:16Z","timestamp":1775946796000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2026-003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/immunohematology-2026-003"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2026-003","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}